PharmaEngine, Inc. (4162)
Market Closed
10 Aug, 05:30
TWSE 
NT$
64. 70
+1
+1.5699%
NT$
- Market Cap
12.44 P/E Ratio
0.88% Div Yield
520,809 Volume
0.78 Eps
NT$ 63.7
Previous Close Want to track 4162 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
PharmaEngine, Inc. (4162) Statistics
Valuation metrics
Market Cap -
Enterprise value 7.87B
Trailing P/E (ttm) 21.67
Forward P/E -
PEG ratio -0.28
Price/Sales (ttm) 9.5
Price/Book (mrq) 1.81
Enterprise Value/Revenue 8.16
Enterprise Value/EBITDA 13.97
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 448.62K
Average volume (90 days) 712.62K
Price summary
52-Week low 53
52-Week high 79.2
Beta -
50-Day moving average 63.19
200-Day moving average 60.25
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 6
Trailing annual dividend yield 0.0942%
5-Year annual dividend yield -
Payout ratio 2.04
Dividend Date 29 Aug 2025
Ex-Dividend Date 13 Aug 2025
Last split factor 1,199:1,000
Last split Date 26 Jul 2017
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.44%
Operating margin 0.48%
Operational effectiveness
Return on assets 0.08%
Return on equity 0.09%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 6.71
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 2.94
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 34.63
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 29.16%
Book value per share (mrq) 35.24
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
